Diana Kerwin
About
Diana Kerwin is a scholar working on Psychiatry and Mental health, Public Health, Environmental and Occupational Health and Physiology.
According to data from OpenAlex, Diana Kerwin has authored 31 papers receiving a total of 714 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Psychiatry and Mental health, 7 papers in Public Health, Environmental and Occupational Health and 7 papers in Physiology. Recurrent topics in Diana Kerwin's work include Dementia and Cognitive Impairment Research (15 papers), Alzheimer's disease research and treatments (5 papers) and Advanced Neuroimaging Techniques and Applications (5 papers). Diana Kerwin is often cited by papers focused on Dementia and Cognitive Impairment Research (15 papers), Alzheimer's disease research and treatments (5 papers) and Advanced Neuroimaging Techniques and Applications (5 papers). Diana Kerwin collaborates with scholars based in United States, Japan and United Kingdom. Diana Kerwin's co-authors include Gary J. Martin, Philip Greenland, Erin K. O’Brien, Kiang Liu, Heather C. Kaplan, Mary Mcdermott, C. Munro Cullum, Rong Zhang, David Geldmacher and Takashi Tarumi and has published in prestigious journals such as NeuroImage, Neurology and Journal of the American Geriatrics Society.
In The Last Decade
Diana Kerwin
30 papers receiving 692 citations
Peers
Diana Kerwin
Mao Shibata Japan
Aozhou Wu United States
Gregory A. Dore United States
Vincentius J.A. Verlinden Netherlands
Kendra Davis‐Plourde United States
Sarah A. Gaussoin United States
Patrick Griffith United States
Adina Zeki Al Hazzouri United States
Carrington R. Wendell United States
Marcel Olde‐Rikkert Netherlands
Citations per year, relative to Diana Kerwin Diana Kerwin (= 1×)
peers
Mao Shibata
Countries citing papers authored by Diana Kerwin
Since
Specialization
Citations
This map shows the geographic impact of Diana Kerwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diana Kerwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diana Kerwin more than expected).
Fields of papers citing papers by Diana Kerwin
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Diana Kerwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diana Kerwin. The network helps show where Diana Kerwin may publish in the future.
Co-authorship network of co-authors of Diana Kerwin
This figure shows the co-authorship network connecting the top 25 collaborators of Diana Kerwin. A scholar is included among the top collaborators of Diana Kerwin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diana Kerwin. Diana Kerwin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Borson, Soo, Rhoda Au, Anna Chodos, et al.. (2025). Opportunities to encourage adoption of a biomarker‐enabled care pathway for Alzheimer's in primary care. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 17(1). e70095–e70095.
2.
Mohs, Richard C., et al.. (2024). The Bio‐Hermes Study: Biomarker database developed to investigate blood‐based and digital biomarkers in community‐based, diverse populations clinically screened for Alzheimer's disease. Alzheimer s & Dementia. 20(4). 2752–2765.
3.
Gaudioso, Jennifer M, et al.. (2023). Bio‐Hermes study topline results: Aß 40/42 and p‐tau181/217/231 blood‐based biomarkers compared to amyloid PET and CSF in a diverse, community‐based population. Alzheimer s & Dementia. 19(S24).
4.
Szabo‐Reed, Amanda N., Eric D. Vidoni, Angela Van Sciver, et al.. (2023). Recruitment methods and yield rates for a multisite clinical trial exploring risk reduction for Alzheimer's disease (rrAD). Alzheimer s & Dementia Translational Research & Clinical Interventions. 9(4). e12422–e12422.
5.
Lane, Christopher, Szofia Bullain, Angeliki Thanasopoulou, et al.. (2022). Baseline Characteristics of the GRADUATE Studies: Phase III Randomized, Placebo-Controlled Studies Investigating Subcutaneous Gantenerumab in Participants with Early Alzheimer’s Disease (P16-3.005). Neurology. 98(18_supplement).
6.
Assunção, Sheila Seleri, Reisa A. Sperling, Craig Ritchie, et al.. (2022). Meaningful benefits: a framework to assess disease-modifying therapies in preclinical and early Alzheimer’s disease. Alzheimer s Research & Therapy. 14(1). 54–54.
7.
Mohs, Richard C., et al.. (2022). Bio‐Hermes: A Validation Study to Assess a Meaningful Relationship Between Blood and Digital Biomarkers with Aβ PET Scans for Alzheimer’s Disease. Alzheimer s & Dementia. 18(S5).
8.
Keller, Jeffrey N., Ellen F. Binder, Eric D. Vidoni, et al.. (2022). Evaluation of noise regression techniques in resting-state fMRI studies using data of 434 older adults. Frontiers in Neuroscience. 16. 1006056–1006056.
9.
Szabo‐Reed, Amanda N., Eric D. Vidoni, Ellen F. Binder, et al.. (2019). Rationale and methods for a multicenter clinical trial assessing exercise and intensive vascular risk reduction in preventing dementia (rrAD Study). Contemporary Clinical Trials. 79. 44–54.
10.
Reid, Kieran F., Michael P. Walkup, Jeffrey A. Katula, et al.. (2016). COGNITIVE PERFORMANCE DOES NOT LIMIT PHYSICAL ACTIVITY PARTICIPATION IN THE LIFESTYLE INTERVENTIONS AND INDEPENDENCE FOR ELDERS PILOT STUDY (LIFE-P). The Journal of Prevention of Alzheimer s Disease. 4(1). 1–7.
11.
Tarumi, Takashi, David C. Zhu, B. Tseng, et al.. (2015). Central artery stiffness, baroreflex sensitivity, and brain white matter neuronal fiber integrity in older adults. NeuroImage. 110. 162–170.
12.
Geldmacher, David & Diana Kerwin. (2013). Practical Diagnosis and Management of Dementia Due to Alzheimer’s Disease in the Primary Care Setting. The Primary Care Companion For CNS Disorders. 15(4).
13.
Boxer, Adam L., David S. Knopman, Daniel Kaufer, et al.. (2012). P2‐403: A randomized, multicenter, placebo controlled trial of memantine for behavioral variant FTD and semantic variant PPA. Alzheimer s & Dementia. 8(4S_Part_11).
14.
Kerwin, Diana, Sarah A. Gaussoin, Rowan T. Chlebowski, et al.. (2011). Interaction Between Body Mass Index and Central Adiposity and Risk of Incident Cognitive Impairment and Dementia: Results from the Women's Health Initiative Memory Study. Journal of the American Geriatrics Society. 59(1). 107–112.
15.
Kerwin, Diana & Thomas H. Claus. (2010). Severe Alzheimer’s Disease: Treatment Effects on Function and Care Requirements. Journal of the American Medical Directors Association. 12(2). 99–104.
16.
Kerwin, Diana, Yinghua Zhang, Jane Morley Kotchen, et al.. (2010). The Cross‐Sectional Relationship Between Body Mass Index, Waist–Hip Ratio, and Cognitive Performance in Postmenopausal Women Enrolled in the Women's Health Initiative. Journal of the American Geriatrics Society. 58(8). 1427–1432.
17.
Grossberg, George T., et al.. (2010). The Art of Sharing the Diagnosis and Management of Alzheimer’s Disease With Patients and Caregivers. The Primary Care Companion to The Journal of Clinical Psychiatry. 12(1). PCC.09cs00833–PCC.09cs00833.
18.
Kuller, Lewis H., Karen L. Margolis, Sarah A. Gaussoin, et al.. (2009). Relationship of Hypertension, Blood Pressure, and Blood Pressure Control With White Matter Abnormalities in the Women’s Health Initiative Memory Study (WHIMS)—MRI Trial. Journal of Clinical Hypertension. 12(3). 203–212.
19.
Simpson, Deborah, Diana Kerwin, Dawn Bragg, et al.. (2006). Objective Structured Video Examinations (OSVEs) for Geriatrics Education. Gerontology & Geriatrics Education. 26(4). 7–24.
20.
Mcdermott, Mary, Diana Kerwin, Kiang Liu, et al.. (2001). Prevalence and significance of unrecognized lower extremity peripheral arterial disease in general medicine practice. Journal of General Internal Medicine. 16(6). 384–390.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Mao Shibata Breakdown of academic impact, for papers by Aozhou Wu Breakdown of academic impact, for papers by Gregory A. Dore Breakdown of academic impact, for papers by Vincentius J.A. Verlinden Breakdown of academic impact, for papers by Kendra Davis‐Plourde Breakdown of academic impact, for papers by Sarah A. Gaussoin Breakdown of academic impact, for papers by Patrick Griffith Breakdown of academic impact, for papers by Adina Zeki Al Hazzouri Breakdown of academic impact, for papers by Carrington R. Wendell Breakdown of academic impact, for papers by Marcel Olde‐Rikkert